Signal Genetics (SGNL) Misses Q1 EPS Views

Signal Genetics (NASDAQ: SGNL) reported Q1 EPS of ($0.45), $0.09 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $645 thousand versus the consensus estimate of $1.9 million.

For earnings history and earnings-related data on Signal Genetics (SGNL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c